Cargando…

China Stroke Statistics 2019: A Report From the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations

China faces the greatest challenge from stroke in the world. The death rate for cerebrovascular diseases in China was 149.49 per 100 000, accounting for 1.57 million deaths in 2018. It ranked third among the leading causes of death behind malignant tumours and heart disease. The age-standardised pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yong-Jun, Li, Zi-Xiao, Gu, Hong-Qiu, Zhai, Yi, Jiang, Yong, Zhao, Xing-Quan, Wang, Yi-Long, Yang, Xin, Wang, Chun-Juan, Meng, Xia, Li, Hao, Liu, Li-Ping, Jing, Jing, Wu, Jing, Xu, An-Ding, Dong, Qiang, Wang, David, Zhao, Ji-Zong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548521/
https://www.ncbi.nlm.nih.gov/pubmed/32826385
http://dx.doi.org/10.1136/svn-2020-000457
_version_ 1783592633410519040
author Wang, Yong-Jun
Li, Zi-Xiao
Gu, Hong-Qiu
Zhai, Yi
Jiang, Yong
Zhao, Xing-Quan
Wang, Yi-Long
Yang, Xin
Wang, Chun-Juan
Meng, Xia
Li, Hao
Liu, Li-Ping
Jing, Jing
Wu, Jing
Xu, An-Ding
Dong, Qiang
Wang, David
Zhao, Ji-Zong
author_facet Wang, Yong-Jun
Li, Zi-Xiao
Gu, Hong-Qiu
Zhai, Yi
Jiang, Yong
Zhao, Xing-Quan
Wang, Yi-Long
Yang, Xin
Wang, Chun-Juan
Meng, Xia
Li, Hao
Liu, Li-Ping
Jing, Jing
Wu, Jing
Xu, An-Ding
Dong, Qiang
Wang, David
Zhao, Ji-Zong
author_sort Wang, Yong-Jun
collection PubMed
description China faces the greatest challenge from stroke in the world. The death rate for cerebrovascular diseases in China was 149.49 per 100 000, accounting for 1.57 million deaths in 2018. It ranked third among the leading causes of death behind malignant tumours and heart disease. The age-standardised prevalence and incidence of stroke in 2013 were 1114.8 per 100 000 population and 246.8 per 100 000 person-years, respectively. According to the Global Burden of Disease Study 2017, the years of life lost (YLLs) per 100 000 population for stroke increased by 14.6%; YLLs due to stroke rose from third highest among all causes in 1990 to the highest in 2017. The absolute numbers and rates per 100 000 population for all-age disability-adjusted life years (DALYs) for stroke increased substantially between 1990 and 2017, and stroke was the leading cause of all-age DALYs in 2017. The main contributors to cerebrovascular diseases include behavioural risk factors (smoking and alcohol use) and pre-existing conditions (hypertension, diabetes mellitus, dyslipidaemia and atrial fibrillation (AF)). The most prevalent risk factors among stroke survivors were hypertension (63.0%-84.2%) and smoking (31.7%-47.6%). The least prevalent was AF (2.7%-7.4%). The prevalences for major risk factors for stroke are high and most have increased over time. Based on the latest national epidemiological data, 26.6% of adults aged ≥15 years (307.6 million adults) smoked tobacco products. For those aged ≥18 years, age-adjusted prevalence of hypertension was 25.2%; adjusted prevalence of hypercholesterolaemia was 5.8%; and the standardised prevalence of diabetes was 10.9%. For those aged ≥40 years, the standardised prevalence of AF was 2.31%. Data from the Hospital Quality Monitoring System showed that 3 010 204 inpatients with stroke were admitted to 1853 tertiary care hospitals during 2018. Of those, 2 466 785 (81.9%) were ischaemic strokes (ISs); 447 609 (14.9%) were intracerebral haemorrhages (ICHs); and 95 810 (3.2%) were subarachnoid haemorrhages (SAHs). The average age of patients admitted was 66 years old, and nearly 60% were male. A total of 1555 (0.1%), 2774 (0.6%) and 1347 (1.4%) paediatric strokes (age <18 years) were identified among IS, ICH and SAH, respectively. Over one-third (1 063 892 (35.3%)) of the patients were covered by urban resident basic medical insurance, followed by urban employee basic medical insurance (699 513 (23.2%)) and new rural cooperative medical schema (489 361 (16.3%)). The leading risk factor was hypertension (67.4% for IS, 77.2% for ICH and 49.1% for SAH), and the leading comorbidity was pneumonia or pulmonary infection (10.1% for IS, 31.4% for ICH and 25.2% for SAH). In-hospital death/discharge against medical advice rate was 8.3% for stroke inpatients, ranging from 5.8% for IS to 19.5% for ICH. The median and IQR of length of stay was 10.0 (7.0–14.0) days, ranging from 10.0 (7.0–13.0) in IS to 14.0 (8.0–22.0) in SAH. Data from the Chinese Stroke Center Alliance demonstrated that the composite scores of guideline-recommended key performance indicators for patients with IS, ICH and SAH were 0.77±0.21, 0.72±0.28 and 0.59±0.32, respectively.
format Online
Article
Text
id pubmed-7548521
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-75485212020-10-19 China Stroke Statistics 2019: A Report From the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations Wang, Yong-Jun Li, Zi-Xiao Gu, Hong-Qiu Zhai, Yi Jiang, Yong Zhao, Xing-Quan Wang, Yi-Long Yang, Xin Wang, Chun-Juan Meng, Xia Li, Hao Liu, Li-Ping Jing, Jing Wu, Jing Xu, An-Ding Dong, Qiang Wang, David Zhao, Ji-Zong Stroke Vasc Neurol Epidemiological Study China faces the greatest challenge from stroke in the world. The death rate for cerebrovascular diseases in China was 149.49 per 100 000, accounting for 1.57 million deaths in 2018. It ranked third among the leading causes of death behind malignant tumours and heart disease. The age-standardised prevalence and incidence of stroke in 2013 were 1114.8 per 100 000 population and 246.8 per 100 000 person-years, respectively. According to the Global Burden of Disease Study 2017, the years of life lost (YLLs) per 100 000 population for stroke increased by 14.6%; YLLs due to stroke rose from third highest among all causes in 1990 to the highest in 2017. The absolute numbers and rates per 100 000 population for all-age disability-adjusted life years (DALYs) for stroke increased substantially between 1990 and 2017, and stroke was the leading cause of all-age DALYs in 2017. The main contributors to cerebrovascular diseases include behavioural risk factors (smoking and alcohol use) and pre-existing conditions (hypertension, diabetes mellitus, dyslipidaemia and atrial fibrillation (AF)). The most prevalent risk factors among stroke survivors were hypertension (63.0%-84.2%) and smoking (31.7%-47.6%). The least prevalent was AF (2.7%-7.4%). The prevalences for major risk factors for stroke are high and most have increased over time. Based on the latest national epidemiological data, 26.6% of adults aged ≥15 years (307.6 million adults) smoked tobacco products. For those aged ≥18 years, age-adjusted prevalence of hypertension was 25.2%; adjusted prevalence of hypercholesterolaemia was 5.8%; and the standardised prevalence of diabetes was 10.9%. For those aged ≥40 years, the standardised prevalence of AF was 2.31%. Data from the Hospital Quality Monitoring System showed that 3 010 204 inpatients with stroke were admitted to 1853 tertiary care hospitals during 2018. Of those, 2 466 785 (81.9%) were ischaemic strokes (ISs); 447 609 (14.9%) were intracerebral haemorrhages (ICHs); and 95 810 (3.2%) were subarachnoid haemorrhages (SAHs). The average age of patients admitted was 66 years old, and nearly 60% were male. A total of 1555 (0.1%), 2774 (0.6%) and 1347 (1.4%) paediatric strokes (age <18 years) were identified among IS, ICH and SAH, respectively. Over one-third (1 063 892 (35.3%)) of the patients were covered by urban resident basic medical insurance, followed by urban employee basic medical insurance (699 513 (23.2%)) and new rural cooperative medical schema (489 361 (16.3%)). The leading risk factor was hypertension (67.4% for IS, 77.2% for ICH and 49.1% for SAH), and the leading comorbidity was pneumonia or pulmonary infection (10.1% for IS, 31.4% for ICH and 25.2% for SAH). In-hospital death/discharge against medical advice rate was 8.3% for stroke inpatients, ranging from 5.8% for IS to 19.5% for ICH. The median and IQR of length of stay was 10.0 (7.0–14.0) days, ranging from 10.0 (7.0–13.0) in IS to 14.0 (8.0–22.0) in SAH. Data from the Chinese Stroke Center Alliance demonstrated that the composite scores of guideline-recommended key performance indicators for patients with IS, ICH and SAH were 0.77±0.21, 0.72±0.28 and 0.59±0.32, respectively. BMJ Publishing Group 2020-08-21 /pmc/articles/PMC7548521/ /pubmed/32826385 http://dx.doi.org/10.1136/svn-2020-000457 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Epidemiological Study
Wang, Yong-Jun
Li, Zi-Xiao
Gu, Hong-Qiu
Zhai, Yi
Jiang, Yong
Zhao, Xing-Quan
Wang, Yi-Long
Yang, Xin
Wang, Chun-Juan
Meng, Xia
Li, Hao
Liu, Li-Ping
Jing, Jing
Wu, Jing
Xu, An-Ding
Dong, Qiang
Wang, David
Zhao, Ji-Zong
China Stroke Statistics 2019: A Report From the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations
title China Stroke Statistics 2019: A Report From the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations
title_full China Stroke Statistics 2019: A Report From the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations
title_fullStr China Stroke Statistics 2019: A Report From the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations
title_full_unstemmed China Stroke Statistics 2019: A Report From the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations
title_short China Stroke Statistics 2019: A Report From the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations
title_sort china stroke statistics 2019: a report from the national center for healthcare quality management in neurological diseases, china national clinical research center for neurological diseases, the chinese stroke association, national center for chronic and non-communicable disease control and prevention, chinese center for disease control and prevention and institute for global neuroscience and stroke collaborations
topic Epidemiological Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548521/
https://www.ncbi.nlm.nih.gov/pubmed/32826385
http://dx.doi.org/10.1136/svn-2020-000457
work_keys_str_mv AT wangyongjun chinastrokestatistics2019areportfromthenationalcenterforhealthcarequalitymanagementinneurologicaldiseaseschinanationalclinicalresearchcenterforneurologicaldiseasesthechinesestrokeassociationnationalcenterforchronicandnoncommunicablediseasecontrolandpreven
AT lizixiao chinastrokestatistics2019areportfromthenationalcenterforhealthcarequalitymanagementinneurologicaldiseaseschinanationalclinicalresearchcenterforneurologicaldiseasesthechinesestrokeassociationnationalcenterforchronicandnoncommunicablediseasecontrolandpreven
AT guhongqiu chinastrokestatistics2019areportfromthenationalcenterforhealthcarequalitymanagementinneurologicaldiseaseschinanationalclinicalresearchcenterforneurologicaldiseasesthechinesestrokeassociationnationalcenterforchronicandnoncommunicablediseasecontrolandpreven
AT zhaiyi chinastrokestatistics2019areportfromthenationalcenterforhealthcarequalitymanagementinneurologicaldiseaseschinanationalclinicalresearchcenterforneurologicaldiseasesthechinesestrokeassociationnationalcenterforchronicandnoncommunicablediseasecontrolandpreven
AT jiangyong chinastrokestatistics2019areportfromthenationalcenterforhealthcarequalitymanagementinneurologicaldiseaseschinanationalclinicalresearchcenterforneurologicaldiseasesthechinesestrokeassociationnationalcenterforchronicandnoncommunicablediseasecontrolandpreven
AT zhaoxingquan chinastrokestatistics2019areportfromthenationalcenterforhealthcarequalitymanagementinneurologicaldiseaseschinanationalclinicalresearchcenterforneurologicaldiseasesthechinesestrokeassociationnationalcenterforchronicandnoncommunicablediseasecontrolandpreven
AT wangyilong chinastrokestatistics2019areportfromthenationalcenterforhealthcarequalitymanagementinneurologicaldiseaseschinanationalclinicalresearchcenterforneurologicaldiseasesthechinesestrokeassociationnationalcenterforchronicandnoncommunicablediseasecontrolandpreven
AT yangxin chinastrokestatistics2019areportfromthenationalcenterforhealthcarequalitymanagementinneurologicaldiseaseschinanationalclinicalresearchcenterforneurologicaldiseasesthechinesestrokeassociationnationalcenterforchronicandnoncommunicablediseasecontrolandpreven
AT wangchunjuan chinastrokestatistics2019areportfromthenationalcenterforhealthcarequalitymanagementinneurologicaldiseaseschinanationalclinicalresearchcenterforneurologicaldiseasesthechinesestrokeassociationnationalcenterforchronicandnoncommunicablediseasecontrolandpreven
AT mengxia chinastrokestatistics2019areportfromthenationalcenterforhealthcarequalitymanagementinneurologicaldiseaseschinanationalclinicalresearchcenterforneurologicaldiseasesthechinesestrokeassociationnationalcenterforchronicandnoncommunicablediseasecontrolandpreven
AT lihao chinastrokestatistics2019areportfromthenationalcenterforhealthcarequalitymanagementinneurologicaldiseaseschinanationalclinicalresearchcenterforneurologicaldiseasesthechinesestrokeassociationnationalcenterforchronicandnoncommunicablediseasecontrolandpreven
AT liuliping chinastrokestatistics2019areportfromthenationalcenterforhealthcarequalitymanagementinneurologicaldiseaseschinanationalclinicalresearchcenterforneurologicaldiseasesthechinesestrokeassociationnationalcenterforchronicandnoncommunicablediseasecontrolandpreven
AT jingjing chinastrokestatistics2019areportfromthenationalcenterforhealthcarequalitymanagementinneurologicaldiseaseschinanationalclinicalresearchcenterforneurologicaldiseasesthechinesestrokeassociationnationalcenterforchronicandnoncommunicablediseasecontrolandpreven
AT wujing chinastrokestatistics2019areportfromthenationalcenterforhealthcarequalitymanagementinneurologicaldiseaseschinanationalclinicalresearchcenterforneurologicaldiseasesthechinesestrokeassociationnationalcenterforchronicandnoncommunicablediseasecontrolandpreven
AT xuanding chinastrokestatistics2019areportfromthenationalcenterforhealthcarequalitymanagementinneurologicaldiseaseschinanationalclinicalresearchcenterforneurologicaldiseasesthechinesestrokeassociationnationalcenterforchronicandnoncommunicablediseasecontrolandpreven
AT dongqiang chinastrokestatistics2019areportfromthenationalcenterforhealthcarequalitymanagementinneurologicaldiseaseschinanationalclinicalresearchcenterforneurologicaldiseasesthechinesestrokeassociationnationalcenterforchronicandnoncommunicablediseasecontrolandpreven
AT wangdavid chinastrokestatistics2019areportfromthenationalcenterforhealthcarequalitymanagementinneurologicaldiseaseschinanationalclinicalresearchcenterforneurologicaldiseasesthechinesestrokeassociationnationalcenterforchronicandnoncommunicablediseasecontrolandpreven
AT zhaojizong chinastrokestatistics2019areportfromthenationalcenterforhealthcarequalitymanagementinneurologicaldiseaseschinanationalclinicalresearchcenterforneurologicaldiseasesthechinesestrokeassociationnationalcenterforchronicandnoncommunicablediseasecontrolandpreven
AT chinastrokestatistics2019areportfromthenationalcenterforhealthcarequalitymanagementinneurologicaldiseaseschinanationalclinicalresearchcenterforneurologicaldiseasesthechinesestrokeassociationnationalcenterforchronicandnoncommunicablediseasecontrolandpreven